Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

34.41 -0.15 (-0.43%)
Streaming Delayed Price Updated: 9:53 AM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 110,030
Open 34.64
Bid (Size) 34.40 (3)
Ask (Size) 34.42 (4)
Prev. Close 34.56
Today's Range 34.14 - 34.75
52wk Range 26.38 - 52.47
Shares Outstanding 671,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets

Performance

YTD
+24.63%
+24.63%
1 Month
+17.92%
+17.92%
3 Month
+8.96%
+8.96%
6 Month
-15.60%
-15.60%
1 Year
-29.79%
-29.79%

More News

Read More
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
Via Benzinga
Why Teladoc Stock Popped 5% Today
Via The Motley Fool
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
Via Talk Markets
Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
Via Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
Via Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
Via Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
Via Benzinga
Precious Metals Outperformed Stocks And Bonds In 2022
Via Talk Markets
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
Via The Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
Via Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Via Benzinga
Getting Ready For The Coming Stock Market Elevator Drop
Via Talk Markets
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
Via Benzinga
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Via The Motley Fool
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Via Benzinga
Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada
Via Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
Via Benzinga
ARK Invest Short Sellers Have $2.3B In Profits So Far In 2022
Via Benzinga
Cathie Wood Sells $2.8M In Healthcare Stock Buoyed By Amazon-Linked Rumors
Via Benzinga
Cathie Wood Splurges $22M To Hike Stake In This Chipmaker Stock Worrying Jim Cramer
Via Benzinga
Cathie Wood Loads Up $23M Worth Of Shares In This Gene-Editing Company As Stock Falls Over 10% In A Month
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.